Breast cancer — risk reduction
- Reserve medication for women with sufficiently elevated risk
- Tamoxifen reduces ER-positive breast-cancer risk
- Raloxifene is an option after menopause
- Aromatase inhibitor is another postmenopausal option
- Balance benefit against VTE/endometrial/bone effects
- Genetics and enhanced screening may matter more in very high risk
Use at a glance
- Reserve medication for women with sufficiently elevated risk
Practical pearls
- Raloxifene is an option after menopause
Other practical pearls
- Aromatase inhibitor is another postmenopausal option
- Balance benefit against VTE/endometrial/bone effects
Escalation / refractory disease
- Tamoxifen reduces ER-positive breast-cancer risk
- Genetics and enhanced screening may matter more in very high risk
Self-check
- When should medication be used in Breast cancer — risk reduction?
women with sufficiently.
Drugs used for this (2)
All clinical uses · Open the interactive console ↗
